International Cannabis Weekly: 291

ZURICH TO LEGALISE CONSUMPTION AND SALE OF CANNABIS IN TRIAL SCHEME

The Swiss government has approved Zurich’s plan to launch a trial program for the consumption and sale of cannabis, expected to start this summer. Switzerland is expanding its pilot scheme on cannabis legalization to study the effects of legalization on the population. The pilot program aims to provide a clearer picture of the impact of cannabis legalization in the country.

READ MORE »

NEW YORK ASSEMBLY URGES AUDIT OF STATE’S LEGAL CANNABIS PROGRAMME

READ MORE »

MANY EUROPEAN COUNTRIES CONSIDERING THE LEGALISATION OF CANNABIS

READ MORE »

• Cannabis on prescription – general practitioners can continue to prescribe in Germany.
• Malta announces rules that cannabis clubs must adhere to, and these rules have been criticised.
• Slated for completion in 2024, a large medical cannabis facility is planned for central Portugal.
• Legalisation of cannabis: France will follow the German bill “closely” to see the evolution of the legislative framework.
• What are the benefits of the revolutionary F1 cannabis hybrids from Royal Queen Seeds?
• The Economic, Social and Environmental Council of France recommends that the government legalise cannabis.
• A batch of applications for CBD products submitted by a UK trade group has been advanced.

CANNABIS EUROPA LONDON – TICKET PRICES INCREASING SOON

Cannabis Europa London is now just 6 weeks away, at a time of great intrigue around the potential of the emerging European cannabis market.

Navigate the European cannabis market by joining 1,500+ industry leaders, investors, academics and regulators at Cannabis Europa London in just 6 weeks time. Meet the right people to help expand your business, share insights, and make crucial business connections.

Our 2nd Release tickets end on 31 March 2023, so get yours now before prices go up!

READ MORE »

• Direct payments from opioid producers to pain doctors in the US have seen a significant decline.
• A bill regulating delta-8 tetrahydrocannabinol has headed to Kentucky Governor Andy Beshear’s desk.
• New York bill to require health insurance coverage of medical cannabis clears Assembly committee.
• The Mississippi legislature has approved a bill that makes several changes to the state’s medical cannabis legalisation.
• Texas lawmakers have approved a bill that would allow doctors to recommend medical cannabis to patients.
• US lawmakers have re-introduced two bills to create a legal framework for hemp-derived cannabinoids.
• Minnesota senators in the latest panel of a key committee have advanced a bill to legalise cannabis.
• Acreage obtains final order for US strategic arrangement with Canopy and Canopy USA.

• New hyper-detailed images of cannabis by the Canadian Light Source help researchers find optimal harvest times.
• Hexo Corp. reported a net loss of C$11.1 million in its latest quarter, up from a year earlier.
• InMed reports second quarter fiscal 2023 financial results and provides business update.
• High Tide reports second consecutive quarter of record revenue and adjusted EBITDA.

PRE-REGISTER FOR THE EUROPEAN CANNABIS REPORT: 8TH EDITION, 2023

The European Cannabis Report: 8th Edition, 2023 provides the latest information and analysis on the development of the cannabis markets across Europe. Included in the report are deep dives into all key sectors and geographic regions in the European cannabis industry, with many data sources which have been exclusively obtained by Prohibition Partners, or else remain un-reported to date.

As well as the free-to-download version of The European Cannabis Report: 8th Edition, there are Premium Packages available that provide additional specialist information and data analytics to help connect with the industry, make smarter decisions, maximise marketing impact and improve business performance.

PRE-REGISTER NOW »

• Court of Justice in Brazil makes historic decision on the cultivation of medicinal cannabis.
• Do the new regulations for medicinal cannabis in Peru restrict patients from access?
• Xebra Brands CEO explains the value of exclusivity with COFEPRIS cannabis approval.
• Brazilian Minister of Agriculture defends the cultivation of medicinal cannabis and hemp.
• In Argentina, 39% of people have said they would be willing to use medical cannabis as a treatment.
• Lawyers explain the progress of medical cannabis cultivation and use in Brazil’s congress.
• Laura Sandoval has confirmed that there is a Juninense company in the hemp business.

• Sydney study finds balanced oil preparations to be safe and effective for older patients.
• The future of Medlab to be settled next month as directors ponder offers to buy or partner.
• Around 60% of patients with Parkinson’s disease and multiple sclerosis said cannabis was beneficial.
• Prime Minister Datuk Seri Anwar Ibrahim says medical use of cannabis in Malaysia needs in-depth study.
• One Nation bill would see any GP in Australia able to prescribe medicinal cannabis.

• Zimbabwe needs to simultaneously build out infrastructure and expand research for hemp to be successful.
• Cannabis Expo returns to GrandWest in Cape Town, South Africa, with its biggest expo yet.
• According to the international market research company EuroMonitor, in 2024 Israel may approve legalisation.
• South African law states that landlords cannot cancel a lease agreement because the tenant smokes cannabis on the property.